Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial. Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, et al. Blood 2025;146:2293-2305.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, et al. Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial. Blood 2025;146:2293-2305.
PMID: 40737595